DiaCarta has acquired CE/IVD marking for its QuantiVirus SARS-CoV-2 Variant Detection Test, permitting commercialisation in the European Union and different global markets. The multiplex qPCR-based take a look at is designed to establish the SARS-CoV-2 virus and its variants. The firm is also in search of US regulatory approval for the test’s emergency use. Swiss firm Achiko, by way of its subsidiary PT Achiko Medika Indonesia, has acquired product and registration emergency use approval…